Format

Send to:

Choose Destination
See comment in PubMed Commons below
Curr Urol Rep. 2007 May;8(3):185-9.

Testosterone replacement therapy and prostate cancer: a word of caution.

Author information

  • 1Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA. brandt2@uthscsa.edu

Abstract

The number of men for whom testosterone is prescribed is rapidly increasing. The aging man normally demonstrates a gradual decline in testosterone. Symptoms of hypogonadism include erectile dysfunction, diminished libido, sarcopenia, increased adiposity, osteopenia and osteoporosis, impaired cognition, and depression. There is a paucity of data regarding both efficacy and safety of testosterone replacement therapy. Testosterone levels have been shown to modulate prostate cancer risk and progression. A prospective evaluation of prostate cancer risk with testosterone replacement therapy has not been conducted. We outline concerns and recommendations for the use of testosterone replacement therapy in the aging man.

PMID:
17459266
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk